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THE PHYSIOLOGY OF VASODILATATION*
LLOYD BECK&dagger;, PH.D. AND MICHAEL J. BRODY,$ PH.D.
INTRODUCTION
In undertaking this paper, no attempt has
been made to include a comprehensive bibliog-
raphy of the copious literature on the subject.
Rather an effort has been made to hold references
to a minimum, citing only that literature which
represents a major advance to the knowledge
and understanding of the subject of reflex dilata-
tion.
Since the terms active and passive dilatation
will be used frequently in this paper it is perhaps
appropriate at the outset to state the context
in which these terms are used. Passive dilatation
refers to the vascular relaxation which occurs
when tonic secretion of a constrictor substance
is interrupted. The existence of neurogenic tone
is therefore a prerequisite if passive reflex dilata-
tion is to occur. It also follows as a corollary that
the maximal possible amount of passive reflex
dilatation is determined by the amount of
existing tone. Active dilatation refers to the
vascular relaxation following the endogenous
release or the exogenous administration of a
substance capable of decreasing tone by a
direct action on the blood vessel. In contrast to
passive dilatation which is brought about by a
decrease in constrictor substance, active dilata-
tion reflects an increase in vaso-active substance
at the blood vessel level. Active dilatation also
differs from passive dilatation in that neurogenic
constrictor tone is not a prerequisite for active
reflex dilatation to occur. It is only necessary
that vascular tone be present irrespective of
whether it is neurogenic, humoral, or intrinsic in
origin. The magnitude of active dilatation, on
the other hand, is determined by the extent of
total vascular tone. In rare instances, such as
the intra-arterial injection of serotonin, dilata-
tion may not occur without an intact sympathetic
supply even though the tone remains largely
unchanged.
REFLEX MECHANISMS AVAILABLE FOR THE PRO-
DUCTION OF PASSIVE REFLEX DILATATION
In the past few years there have been several
excellent reviews on this subject. The papers by
Dawes and Comroe3° and by Aviado and Schmidt5
summarize most of the pertinent literature and
critically integrate the findings of the numerous
investigators. The more recent monograph of
Heymans and N eil58 deals expansively with the
subject of buffer mechanisms, its historical
development, its anatomic basis and its physio-
logic integration. Several other recent sources
provide valuable additional information and
discuss the concepts involved.’, 23. 37, 46, 76, 94, 111,
113,114 To re-state the work contained in these
recent authoritative reviews would only be
repetitive. Instead a summary of passive reflex
mechanisms and their pathways will be presented
for the more facile understanding by those
students whose special interests lie in more
peripheral areas. The dedicated student with
deep-rooted and enduring interest in the delicacies
of autonomic vascular control is referred to the
above sources or to the original literature for a
comprehensive and critical coverage.
The most well known and probably the most
important mechanisms capable of producing
passive reflex dilatation are the carotid sinus and
aortic arch buffer systems. In both of these
regions are located specialized afferent receptors
which respond either to vascular distension or to
stretch. The stretch initiates a volley of impulses
which pass centrally over the sinus or vago-
depressor branch of the vagus to inhibit tonic
discharge of the vasomotor center. The inhibition
of vasomotor activity results in the passage of
fewer sympathetic impulses to the peripheral
blood vessels. Consequently, less norepinephrine
is released from the nerve endings; that nor-
epinephrine previously discharged is quickly
terminated by enzymes present in the vessel,
the free norepinephrine concentration quickly
falls, and the vessel relaxes.
The existence and importance of these reflexes
are well documented. The contention that these
reflexes are responsible for the primary control of
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blood pressure is supported by the well sub-
stantiated observations that carotid occlusion
results in a reflex rise in blood pressure, that
combined sinusectomy and vagotomy result in a
marked and sustained rise in blood pressure, and,
conversely, that maneuvers such as increasing
the sinus pressure or painting the sinuses with
norepinephrine, or electrically stimulating the
sinus nerves result in reflex hypotension. These
observations lead to the concept that the vaso-
motor center has an inherent tendency to dis-
charge at a high level of activity but is held in
check by the inhibitory input from these pressure
sensitive zones. The injection of a pressor sub-
stance, by elevating the blood pressure, would
increase the inhibitory input from such areas
and, by decreasing the secretion of endogenous
catechol amines, would result in passive reflex
dilatation.
Several other reflexes have been described
which produce a reflex lowering in blood pressure
and which are assumed to operate as vasomotor
inhibitory systems. Two of these, the pulmonary
depressor reflex and the coronary chemoreflex
(part of the Bezold-Jarisch reflex) are initiated
by chemical stimulation rather than by stretch.
The afferent receptors of the former reflex are
located in the distribution of the pulmonary
artery. The afferent receptors of the coronary
chemoreflex are in the distribution of the coronary
artery and the pulmonary vein, the relative
contribution from these sources being species
dependent. Impulses initiated from these areas
by specific chemical stimuli pass centrally over
the vagus. The central distribution and mecha-
nism of action of these reflexes has been assumed
to be similar to those arising from the sinus and
aortic arch; that is, that these reflexes also
operate to produce passive reflex dilatation
through inhibition of sympathetic tone.
It has long been recognized that afferent
splanchnic stimulation can produce a reflex fall
in blood pressure.21, 22 Gruhzit and associates’6
demonstrated that epinephrine, and to a lesser
extent norepinephrine, is capable of producing a
reflex dilatation in the cross-circulated hindlimb
of the dog after sinusectomy and vagotomy
Gruhzit and his colleagues proposed that the
receptors for the reflex were located along the
distribution of the aorta and coined the name
mechanoreceptors, because they felt that the
receptors discharge in response to pulse pressure.
They reported that the reflex response to epi-
nephrine after sinusectomy and vagotomy was
abolished by section of the dorsal thoracic roots.
Recent interest has been aroused in the functional
role of receptors located in the mesenteric
distribution. Sarnoff and Xamada93 believe that
such receptors may tonically influence the blood
pressure of the cat. Heymans and his associates 57
have taken exception to this view and feel that
the response can be explained as an artifact of
the experimental conditions. Recently, however,
Selkurt and Rotheloo have also investigated this
problem. These authors feel that the reflex is of
little consequence in the dog but feel that it is
of more biologic significance in the cat. The
fact that sinusectomy and section of afferents
arising from the aortic and pulmonary vessels
results in a sustained rise in blood pressure which
may last for months or longer questions the
importance of such reflexes in the long term
regulation of blood pressure. They may well be
important in short term regulation of blood
pressure, such as in exercise, shock, and so on, or
they may play an auxiliary or secondary role in
blood pressure regulation. They may well account
for the fact that the blood pressure of the neuro-
genic hypertensive animal ultimately returns
toward normal levels.
A centrally located system capable of producing
reflex dilatation and excited by epinephrine has
been reported by Taylor and Page,1°6.107 Upon
re-investigating this problem Schneider and
associates 97 reported only minimal hypotensive
responses in the recipient body when epinephrine
was injected into the sinusectomized cross-
circulated head. Because of the large dose of
epinephrine required to produce the minimal
hypotensive response they question the physio-
logic importance of such a reflex mechanism.
The level of sympathetic activity in relation to
passive dilatation and its clinical significance.
The therapeutic use of a large number of phar-
macologic agents is based on their ability to
produce passive dilatation. Agents are available
which initiate the Bezold-Jarisch reflex, depress
the vasomotor center by elevating threshold,
block sympathetic ganglia, prevent the release
of norepinephrine from the sympathetic nerve
endings, and block the vasoconstriction produced
by released norepinephrine. Because all of these
agents can only produce passive dilatation,
sympathetic tone must be present if they are to
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be clinically effective. Until recently it was
generally accepted that the normal individual or
animal possessed considerable sympathetic tone
even under basal conditions. This concept has
been questioned. Maxwell and associatesg4 re-
ported that the administration of the ganglion
blocking agent, chlorisondamine, failed to lower
pressure in normal unanesthetized dogs and rats,
and inferred from this observation that sympa-
thetic tone was absent in these species without
anesthesia. A well defined fall was observed in
the unanesthetized monkey and rabbit, however.
Similar conclusions that sympathetic tone is
absent or minimal have been drawn from the
observation that small doses of ganglion blocking
agent, capable of lowering the standing blood
pressure in hypertensive patients, fail to lower
materially the supine blood pressure. The same
observation has been made with relatively small
doses of some of the new norepinephrine anti-
release agents such as bretylium and guanethidine.
If the above observations could be taken as
inarguable evidence of the absence of sympathetic
tone in the resting state, it would have important
implications and consequences. In hypertension,
for example, it would necessarily implicate a
non-neurogenic component as the responsible
factor for the elevated pressure. This in turn
would point up the futility of using agents which
produce passive dilatation to attempt to lower
the blood pressure of the sleeping or bed-ridden
hypertensive patient. If the passive dilating
agent were able to lower only the standing blood
pressure, it would indicate that the sympathetic
tone of the hypertensive patient had increased
so as to prevent a fall in standing pressure. This
would favor the proposal that the barostat or
pressure regulating mechanisms are set at a
higher level in the hypertensive patient.
Not all researchers are in agreement, however,
that sympathetic tone is virtually absent in the
resting state. In anesthetized animals, where it is
most easy to evaluate sympathetic activity, it is
almost universally agreed that a large complement
of sympathetic tone exists. But it is entirely
possible, and in fact proposed by many, that
anesthesia calls forth an abnormal complement
of sympathetic tone. In an unanesthetized dog,
immobilized by decamethonium, and artificially
respired, Beck’O noted a large reduction in cardiac
output and a considerable fall in blood pressure
following large doses of ganglion blocking agents.
In some experiments currently being carried
out, Dr. Donald Knapp of this department, has
observed a fall in blood pressure after 4 mg per
kg of ostensin or 5 mg per kg of hexamethonium
in unanesthetized cats and dogs immobilized
with decamethonium. Mid-pontine section often
produced a further fall in blood pressure follow-
ing ganglionic blockade. Ganglion blocking agents
produced a fall in blood pressure in animals
with a mid-pontine section. The section was
carried out under ether anesthesia. The ganglion
blocking agents were administered 2 hours after
anesthesia to allow the ether to blow off. It is
noteworthy that the pressure responses to the
ganglion stimulating agents, nicotine and di-
methylphenylpiperazinium, were almost totaly
abolished by ostensin, whereas auditory and
visual stimuli were still capable of evoking sharp
rises in blood pressure in non-transected animals
but these responses were not long maintained.
These latter responses occurred more rapidly
than could be accounted for by adrenal discharge.
Laverty and Smirk 74 found that the increase
in hindlimb resistance in spontaneous and renal
hypertensive rats is neurogenically maintained
in that it could be blocked by hexamethonium.
Hexamethonium reduced the blood pressure of
normal, spontaneous and renal hypertensive
rats to less than half, but the floor blood pressure
of the renal hypertensive animals was greater
than that of the other two groups. Using his
indwelling aortic catheter technique&dquo;6 Dr. James
Weeks (unpublished observations) of the Upjohn
Company has also observed a large fall in blood
pressure following administration of large doses
of hexamethonium (10 mg per kg) and tetraethyl-
ammonium (20 mg per kg) in unanesthetized
renal hypertensive rats. The floor pressure ob-
served by Weeks was considerably higher than
that observed by Laverty and Smirk.74 In-
terestingly, doses of 5 mg per kg and 10 mg per
kg of tetraethylammonium appeared to have
little effect on blood pressure either in the un-
anesthetized or anesthetized hypertensive rat.
These observations suggest that some types of
constrictor activity are remarkably resistant to
low doses of ganglion blocking agents but can be
blocked by very large doses. It is possible that
the hypotension is brought about by other than
neurogenic blockade, but this seems doubtful
since hexamethonium may increase the blood
pressure of the unanesthetized spinal cat, and
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has little effect on the blood pressure of dogs
whose spinal cord is perfused with local anesthetic
from the lumbar to cervical areas (personal
observations). The findings of many investigators
are thus not in accord with those of Maxwell and
associates84 who felt that tonic sympathetic
activity to the blood vessels did not exist in the
unanesthetized dog and rat. It raises the question
of whether adequate dosage of blocking agent
had been given to block sympathetic tone to the
blood vessels.
In the human there is also some evidence of
tonic sympathetic activity in essentially basal
states. The patient at bed rest continues to
secrete catecholamines in his urine. High spinal
anesthesia generally produces a fall in blood
pressure even in the supine state. Neurosurgeons
often have difficulty maintaining the blood
pressure immediately following sympathectomy.
These observations are clearly in opposition to
the view that sympathetic tone is virtually absent
in basal states. From a clinical standpoint, an
evaluation of the amount of existing sympathetic
tone is of fundamental importance. It dictates to
a very large extent whether agents capable of
producing passive dilatation through blockade
of neurogenic tone are to be used, or whether
agents capable of producing active dilatation
by direct or reflex means are to be used.
ACTIVE DILATATION
As stated previously, the basis for passive
dilatation is well founded experimentally and
generally accepted. Active reflex dilatation is
neither as well founded nor is it so generally
accepted. Because of the more general con-
troversial nature of the latter area and because of
the sometimes problematic interpretations put
upon data by various investigators, more space
will be devoted to the discussion of this subject.
The concept of a vasodilator center. It is in-
teresting that the same investigator, Claude
Bernard,12.13 was not only the first to demon-
strate passive dilatation by his classic rabbit
ear experiment, but he was also the first to show
active dilatation in the submaxillary gland upon
stimulation of the chorda tympani nerve. This
observation quite naturally led many early
workers to assume the existence of a higher
center which governed active dilatation as well
as a vasoconstrictor center which governed
vasoconstriction. Some of the early workers
maintained that only a vasoconstrictor center
existed and that vasodilatation resulted from
inhibition of tonic vasoconstrictor activity. Thus
the controversy which still exists today was
hotly contested before the turn of the century.
The early work relating to a vasoconstrictor
and vasodepressor center was reviewed in a
monograph by Bayliss in 1923.9 A few significant
observations relating to the early development
of these concepts deserve special mention. Schiff
in 185595 measured the temperature of the dog
paw before and after transection of the medulla
at various levels and found the level of the obex
to be critical in the maintenance of paw tem-
perature. Shortly after in 1873, Dittmar3l made
successive brain sections from above downward
in curarized rabbits and observed no eff ect on
blood pressure until the mid-pontine level was
reached. From this point to a level just above the
obex, successive sections resulted in a progressive
fall in blood pressure. Sections below the obex
produced no further fall in pressure. Ranson and
Billingsley in 191687 explored the floor of the
fourth ventricle for vaso-active areas producing
a fall or rise in blood pressure. They noted an
area in the inferior fovea which produced a
marked pressor response and a discrete region
near the area postrema which produced a marked
depressor response. They also noted that stimula-
tion of other areas led to less pronounced blood
pressure changes, but it was much later when
Wang and Ranson in 1939116 and Alexander in
19461 emphasized the diffuseness of the vasopres-
sor and vasodepressor areas in the brainstem.
In the early phase of the investigation into
the existence of separate vasopressor and vaso-
depressor centers, much emphasis was placed on
the observation that afferent stimulation of most
peripheral nerves would produce depressor re-
sponses at low intensities of stimulation and
pressor responses at greater intensities. In an
excellent deductive research, Ranson and Bill-
ingsley88> s9 were able to show that the afferent
pathways for the depressor and pressor reflexes
ascend in different parts of the spinal cord. A
separation of the central input of the vago-
depressor reflex and the somatic nerve reflex
was reported by Langley in 1912’3 who injected
starch into the internal carotid artery which
apparently produced selective infarction. The
role of the pressor and depressor areas in the
integration of vasomotor reflex activity was
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initially examined by Scott and Roberts in 192398
and by Scott in 1925.99 Scott abolished the reflex
hypotension deriving from central stimulation of
the vagus by cauterization of the medullary
depressor areas of Ranson and Billingsley. He
found that this procedure left unaffected the
reflex hypotension evoked by stimulation of the
central end of the brachial or sciatic nerves. These
observations have been recently confirmed for
vagus and sinus nerve stimulation and left post-
tibial nerve stimulation by Lindgren and Uvnas
in 1954.81 Scott concluded from his observations
that the depressor area was not the &dquo;supreme
vasodilator center&dquo; in that not all vasodilator
reflexes pass through it.
In more recent years much evidence has been
accumulated that stimulation in many parts of
the brain above the medullary area can produce
a rise or fall in blood pressure depending on the
stimulated area, the anesthetic state, and the
physiologic status of the animal. In most cases,
however, it is not possible to determine whether
the fall in blood pressure initiated by stimulation
is active or passive since most often only blood
pressure changes have been measured. Because
the blood pressure bears no necessary relation-
ship to the resistance of the blood vessels as a
whole and particularly no relationship to the
resistance in individual vascular beds, interpreta-
tion of the results in most cases must await further
experimentation. At the moment the only de-
finitive evidence for active dilatation initiated
by central stimulation derives from the work of
the Scandinavian workers which is discussed in
more detail below.33, 34, 45-51, 77-81, 111-113 The current
status of the central nervous control of the
circulation has been presented in a recent
symposium.23
Although much of the work dealing with
higher center control remains obscure, there is,
nevertheless, considerable evidence for neuro-
genically mediated active dilatation. The dilata-
tion obtained by stimulation of the decentralized
dorsal roots (antidromic stimulation) has long
been recognized and has been the subject of
rather intensive investigation. Because histamine
has been implicated in this form of dilatation,
it is covered under the section of the Role of
Histamine in Neurohumoral Transmission. In
more recent years interest in the subject of
active dilatation mediated by neurogenic means
has been stimulated by the observations of
Folkow, Uvnas and their collaborators33, 34, ~-5t. Im-sI, 111-1l3 following their discovery of active
dilatation in the hindlimb of the cat produced by
stimulation in various areas of the brain. Since
the weight of evidence indicates that this system
is cholinergically mediated it is discussed in
more detail under The Sympathetic Cholinergic
System. Impetus was also added by the dis-
covery of Barcroft and associates’ that active
reflex dilatation occurred during fainting. These
workers observed that on fainting the dilatation z
occurring in the forearm of a patient with an ,
intact sympathetic supply was greater than the
dilatation in the forearm in which sympathetic
transmission had been interrupted. The mediator
of this type of dilatation has not been worked
out. The literature pertaining to fainting has
been reviewed by Barcroft and Swan?
Reflex dilatation initiated by pressoreceptor
mechanisms has been generally considered to be
passive in character. In the excellent review by
Heymans and Neip7 the authors concluded that
baroreceptor vasomotor reflexes do not activate
the sympathetic vasodilator nerves (page 43)
and cite as evidence papers by Folkow and
Uvnas, Lindgren and Uvnas, and Frumin, Ngai
and Wang. The Scandinavian workers have
clearly shown that sinus reflexes are not in-
volved in cholinergic vasodilatation mediated
over the sympathetics since reflex dilatation
induced by sinus stimulation was not blocked
by atropine. 51. 81 These authors also excluded
dorsal root contribution in the sinus or vagode-
pressor induced reflex dilatations because they
had previously ligated the spinal medulla at
L-5.81 They assumed that the baroreceptor-
induced type of reflex dilatation was therefore
passive in nature. Folkow and Uvnås51 reported
that dibenamine blocked reflex dilatation pro-
duced by physiologic saline administration. This
observation would not necessarily rule out his-
tamine as a mediator (see below) since diben-
amine has been reported to prevent the release
of histamine. It also has antihistaminic ac-
tions, 55 although not as potent as dibenzyline
which also blocks this type of reflex dilatation to
a variable degree.
Frumin, Ngai and Wang52 investigated reflex
dilatation in the cross-circulated hindlimb of
the dog induced by afferent vagal stimulation
and by de-occluding the previously restricted
blood supply through the carotid arteries. They
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reported that large intra-arterial doses of hy-
dergine or ganglionectomy abolished the reflex
dilatation. Hindlimb dilatation induced by lumbar
sympathetic stimulation could be abolished by
hydergine and large doses of atropine. They
concluded that reflex dilatation induced by
the above means was passive and reflected
an inhibition of the sympathetic vasoconstric-
tor activity. This paper is widely cited as ev-
idence for the absence of active dilatation
induced by baroreceptor mechanisms and there-
fore deserves special attention. Careful perusal
of their records suggests that active reflex dilata-
tion did indeed occur in their experiments.
Attention should be focused on figures 3, 4 and
7 of their paper. In figures 3 and 7 reflex dilata-
tion induced by afferent vagal stimulation and
release of the carotids, respectively, is clearly
blocked by intra-arterial hydergine as the au-
thors have stated. But the post-blocking blood
flow to the limbs, however, does not nearly
approximate the blood flow induced during the
reflex, which it should have done, were the in-
crease during the reflex the simple resultant of
having removed vasoconstrictor tone. In both of
these records the blood flow is two- to three-fold
greater during the reflex than it is after blockade
of the reflex. The failure of blood flow to in-
crease following hydergine might be attributed
to a direct counter vasoconstriction by hydergine
but this mixture does not normally produce a
very marked constriction as compared to the
large vasoconstricting action of some of the other
ergot alkaloids. The fact that adrenergic block-
ade was induced by these large intra-arterial
doses of hydergine may well be misleading
for as will be seen later we have blocked re-
flex dilatation with intravenous doses which
were only about %o the intra-arterial dose
used by these investigators. At these small
dose ranges significant adrenergic blockade does
not usually occur. Further, reflex constriction
induced by several means is not impaired at
these doses in the dog nor is constriction produced
by direct sympathetic stimulation. In the paper
by Frumin and associates, 52 an even clearer
demonstration of active dilatation, without the
complicating factor of drug intervention, is pro-
vided in the last three panels of their figure 4
after the artifactual effects of collateral blood flow
had been obviated in the preparation. Initiating
the reflex produced a three- to six-fold increase
in the resting blood flow of the innervated limb
but failed to increase the blood flow in the
denervated limb. After collateral occlusion the
resting blood flows are similar in both the
innervated and the denervated limbs indicating
that sympathectomy had produced no very
evident release from vasoconstrictor tone, cer-
tainly not a three- to six-fold increase. It there-
fore appears that active dilatation primarily
accounted for the increase in flow in the in-
nervated limb which was prevented in the
denervated limb by the previous sympathectomy.
Thus three of the illustrations by Frumin, Ngai
and Wang suggest the presence of active reflex
dilatation in spite of their conclusion that it
does not occur. Their results, if not their con-
clusions, are thus in accord with our own ob-
servations cited below as well as those of
the French workers, Binet and Burstein.14.15
The latter authors also used the cross-circu-
lated hindlimb preparation of the dog and
evoked reflex dilatation by the administration
of epinephrine to the recipient body. They
concluded that active reflex dilatation must
occur because the reflex dilatation exceeded the
passive dilatation produced by sympathectomy
of the area. They failed to block the reflex by
administration of atropine or to potentiate it by
physostigmine, an observation which is con-
sonant with the later findings of Lindgren and
Uvnas that cholinergic fibers are not involved in
this type of reflex.81
It becomes evident, therefore, that many of
the investigations involving baroreceptor reflexes
and carried out in independent laboratories
yield very similar results. The interpretations of
the results are often at variance, however.
In some cases the conclusions appear to be un-
justified because of the failure to consider other
than classical or well known actions of the
pharmacologic tools utilized in the various
investigations.
Gruhzit, Freyberger, and Moe56 demonstrated
that epinephrine can produce reflex dilatation
in the dog hindlimb following sinusectomy and
vagotomy. They did not attempt to determine
whether this reflex was active or passive in
nature and the question still remains to be
answered.
Recently Litwin, Dil and Aviado82 showed that
active reflex dilatation occurs in the perfused
hindquarters of the dog in response to hypoxia.
208
The response remained after treatment with
bretylium and was abolished by sympathectomy.
It appeared to be partially blocked by atropine.
In our own studies cited below we had observed
an active reflex dilatation following a period of
tracheal occlusion which is very likely the same
phenomenon reported by Aviado and his col-
leagues. In a pre-publication communication
with the above authors, we indicated that we
also felt the active component was partially
blocked by atropine. We are now no longer sure
whether the apparent partial blockade by atropine
is specific or non-specific (see later).
Shaw and associates 101. 102 reported that the
dilator component of the biphasic blood pressure
response produced by large doses of acetylcholine
in the atropinized animal can be blocked by
nicotine and curare. They felt that the dilator
component was not due to an override of the
atropine blockade and theorized that two types
of ganglion cells are present which they refer
to as C (constrictor) and D (dilator) cells. A
recent paper by Gardier and associates54 would
seem to support the view that the depressor
component is a form of Active dilatation. The
pressor component could be essentially abolished
by administration of N , N-diisopropyl-N-isoamyl-
N-diethylaminoethylurea. More definitive ex-
periments will be required to answer this problem.
It is interesting that the latter authors were not
able to block the dilatation by diphenhydramine,
and also discount an override of cholinergic
blockade induced by atropine. The nature of the
dilatation remains obscure.
The active dilatation produced by exercise
will not be discussed in this paper.
There thus exists in the literature a considerable
amount of evidence for the existence of active
dilator mechanisms. The nature of the sub-
stances mediating these active dilator mecha-
nisms will now be discussed.
The sympathetic cholinergic system. In a classic
paper on ergotoxine by Dale29 the &dquo;motor&dquo; effects
of stimulation of sympathetic nerves were found
to be either abolished or reversed by the ad-
ministration of the ergot alkaloids. With regard
to the vasculature it was often found that ergo-
toxine converted sympathetic constriction to a
dilatation. Dale concluded that vasodilator fibers
exist in the sympathetic chain whose effects
are masked by the &dquo;motor&dquo; components of the
complex nerve. The Rogowicz phenomenon
(stimulation of the cervical sympathetic chain
following motor denervation producing contrac-
tion and flushing of the lips) was studied by
Euler and Gaddum (1931).4° These investigators J
felt that the fibers causing the flushing were
identical with those responsible for the motor 
’
response. The phenomenon was believed to be
due to the release of acetylcholine from sympa-
thetic nerves. Burn18> 10 studied the vascular
responses to stimulation of the abdominal sympa-
thetics in the perfused hindend of the eviscerated
dog. Vasodilatation, vasoconstriction, or a com-
bination of the two responses was elicited,
dependent upon the parameters of stimulation.
Intense stimulation of short duration often gave
rise to dilatation, whereas prolonged stimulation
usually resulted in vascular constriction. These
effects were heightened by the infusion of epi-
nephrine previous to the application of the
stimulus. Other variations seen by Burn were
an initial dilatation followed by constriction,
and a dilatation following constriction upon
cessation of stimulation. These results were
confirmed by Schneider.9s B31bring and Burnls,17 17
demonstrated the cholinergic nature of the
sympathetic vasodilators. In perfused hind-
quarters of cats and dogs dilator responses
were potentiated by eserine pretreatment
and abolished by atropine. Venous efhuent
of Ringer’s perfusate collected during sympathetic
stimulation was found to contain acetylcholine
when bioassayed on the leech preparation.
Similar evidence for sympathetic cholinergic
vasodilatation was obtained simultaneously and
independently by Rosenblueth and Cannon
Vasodilatation induced in hindlimbs of cats by
stimulation of the sympathetic chain following
dibenamine was also shown to be cholinergic
by direct assay of venous eflluent.51 The fall in
blood pressure in cats produced by the effiuent
was abolished by atropine and potentiated by
eserine.49 Billbring and Burn 17 were unable to
demonstrate sympathetic vasodilatation in the
skin of the dog either before or after ergotoxine.
The selective distribution of these fibers to the
skeletal muscle has more recently been con-
firmed by Folkow and U vnäs. 51 Evidence that a
sympathetic vasodilatation exists in the ear
skin of the dog has been challenged.17 Folkow
and co-workers argued that the plethysmo-
graphic technique utilized by Biilbring and Burn
was not specifically measuring skin volume,
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but rather included a significant quantity of
skeletal muscle at the base of the ear.
The sympathetic vasodilators were shown to
be true post-ganglionic sympathetic nerves.51
Typical cholinergic dilator responses were ob-
tained in cats following lumbar dorsal root
section and were abolished by pre-ganglionic
degeneration.81
During the past decade, the central nervous
system representation of the sympathetic vaso-
dilator system has been investigated in some
detail. A pathway from the motor cortex to the
spinal cord has been rather specifically traced
utilizing the Horsley-Clarke technique, histologic
identification of positive dilator areas, and
cholinergic blockade with suitable low doses of
atropine.17-10
Eliasson and associates33, 34 were able to evoke
cholinergic vasodilator discharge by stimulating
an area in the motor cortex near the cruciate
sulcus. The efferent projections from this area
pass caudally to the hypothalamus at which
point there is apparently a neuronal relay.
Evidence favoring a neuronal relay derives from
the experimental observation that cholinergic
dilatations can be produced at the hypothalamic
level in chronic decorticate animals. At the
posterior end of the hypothalamic area, the tract
passes dorsally to the collicular area, where
another neuronal relay has been identified by
medullary stimulation in chronically supracol-
licularly decerebrate dogs. From the collicular
area the pathway turns ventrally and passes
through the ventrolateral portion of the medulla
to the lateral horn of the spinal medulla. The
authors state that cross-circulation of the hind-
limbs has in all of the above-mentioned in-
vestigations been used to establish definitely
the peripheral neurogenic nature of the dilator
system. Moreover, Folkow and Gernandt48 ob-
served increased activity of an electroneurogram
from the peroneal nerve upon excitation of the
hypothalamic cholinergic vasodilator area. Supra-
bulbar stimulation resulted in bilateral hindlimb
dilatation, whereas medullary stimulation pro-
duced the typical response in the ipsilateral
limb only.
In summary, a cholinergic vasodilator system
with extensive central representation has been
demonstrated in cats and dogs. Excitation of this
system results in active dilatation of skeletal
muscle vasculature. The physiologic significance
of the sympathetic cholinergic dilators is un-
known.
Polypeptides and reflex dilatation. Sev eral vaso-
active polypeptides have been known to exist for
a number of years. Advances in chemical tech-
niques have permitted the synthesis of vaso-
pressin, oxytocin, angiotensin and bradykinin.
Following synthesis it has been found that
extremely small quantities of these compounds
are capable of producing vasoconstriction or
vasodilatation depending on the compound. The
marked activity of these compounds naturally
raises the question of whether they are involved
in reflex mechanisms governing the vasculature.
Although vasopressin may be liberated by
afferent vagal stimulation or asphyxia it is
presumed to be released from the posterior
pituitary or neighboring structures.25 There is no
evidence as yet that it is reflexly released from
other areas. The primary evidence to date is that
angiotensin is formed from plasma proteins by
the action of an enzyme renin which is released
from the kidney or possibly from other sources.
It is generally presumed that the release of
renin is not dependent upon neurogenic influences
but the observations of Taquini and associates’05
that spinal pithing lowers the blood pressure of
the renal hypertensive rat to the same level as
the spinal pithed normal rat raises an interesting
question in this regard. (Compare these findings
to those of Laverty and Smirk,74 and Weeks,
unpublished observations, cited previously.)
A great deal of work has recently been carried
out on the kinins. The subject has been recently
reviewed by Lewis.7 At present it is believed that
the kinin-forming enzymes exist as inactive
precursors which when activated, form kinins
from plasma globulin. Whether there are a large
number of kinins or perhaps only one is not yet
known. Most work has been done with the kinin
known as bradykinin which has been recently
synthesized and found to be a nonapeptide. The
preliminary pharmacology carried out with this
substance suggests that it is identical with the
natural bradykinin .71 The recent interest in
the possibility that bradykinin is important in
vasoregulation derives primarily from studies
of Hilton and Lewis59-63 who showed that
kallikrein could be obtained from the venous
effluent and the secretions of the salivary gland
after stimulation of the chorda tympani. The
question which remains to be satisfactorily
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answered is whether an enzyme, released by
nerve stimulation, can produce kinin rapidly
enough to dilate effectively the vessels in the
area in which it is released. This consideration is
of less importance when considering relatively
static blood flow states such as those required to
produce reactive hyperemia, but is a very im-
portant consideration from the standpoint of
whether such a mechanism could operate where
maximal reflex dilatation is produced in a very
brief period of time. Direct release of a preformed
dilator would seem much more appropriate under
the latter circumstances. In this connection,
Hilton and Lewis were not able to find a plasma
kinin nor a quick-acting kinin forming enzyme
upon antidromic stimulation to the perfused skin
of the cat hindlimb. They also failed to detect
kinin upon stimulation of the nerves to gastroc-
nemius muscle. Thus while kallikrein can be
found in many glandular tissues, in the blood
and in the urine, the physiologic role of the
kinins as vascular regulating agents remains to
be fully established.
Another polypeptide known as substance P
was first isolated by Euler and Gaddum.39 This
substance is also a strong vasodilator. The
exact potency is unknown since as yet it has
never been synthesized. It is found in the gastro-
intestinal tract and in many areas of the brain.53
As yet it has not been implicated as a neuro-
genically released dilator.
An excellent and well referenced coverage of
the literature pertaining to the polypeptides
can be found in the proceedings of a symposium
on polypeptides edited by Dr. M. Schacter.94
Lipoproteins have been reviewed by Vogt.114
The role of histamine in neuroh2,emoral trans-
mission. Barger and Dales demonstrated that
histamine was a normal constituent of body
tissues. It is now well accepted that histamine
exhibits an unusually wide distribution; only
bone and cartilage have not been examined for
their histamine content, but all other body
components do contain the amine although in
widely varying quantities The variation in
organ content from species to species is also a
factor that has been considered in studies on
histamine distribution.35, 36, 41, mr
The ubiquity of this potent dilator material
has prompted many investigations into de-
termination of a possible role of histamine as a
vasodilator in various physiologic and pathologic
occurrences Among these may be included the
anaphylactic reaction, headache, the &dquo;triple
response&dquo; of Lewis, antidromic vasodilatation,
post-occlusion hyperemia, functional hyperemia
of exercise and gastric secretion. In this discussion
emphasis has been placed on the considered role
of histamine as a chemical mediator between
nerve and effector cells.
Kwiatkowski72 was the first to demonstrate
the presence of histamine in nervous tissue.
He reported &dquo;high&dquo; levels in dorsal root fibers,
Coujard27 utilized a mercury precipitation histo-
logic technique claimed to be specific for histamine
and found &dquo;histaminergic&dquo; nerves in Auerbach’s
plexus. The distribution of histamine in au-
tonomic nerve fibers was examined in considerable
detail by Euler35> 36 and by Rexed and Euler.11
Post-ganglionic fibers of the sympathetic system
were found to possess the highest concentrations
of histamine when compared with other au-
tonomic nerves.3s, 118 The splenic nerve of oxen
was found to contain the highest quantity
averaging approximately 100 jug per gram of
tissue. An attempt was made to correlate
histamine and noradrenaline content of post-
ganglionic sympathetic fibers.41 In several species,
those nerves rich in catecholamine were often
found to contain also the highest concentration
of histamine. However, wide variations in
histamine to noradrenaline ratios were observed
between the species studied (sheep, dog, cat,
rabbits, oxen and guinea pigs). Similarly both
histamine and noradrenaline concentrations were
dominant in nerves possessing unmyelinated
fibers, anatomically the post-ganglionic fibers
of sympathetic origin. The well known correla-
tion between the noradrenaline content of a
sympathetic nerve and its organ of innervation
does not hold for histamine. For example, in
oxen, the splenic nerve and the post-ganglionic
nerves to the ileum contain 60 to 100 Mg per
gram of histamine whereas the spleen contains
6 to 10 and the ileum 80 to 100 jug per gram.
Unlike the noradrenaline content of organs which
falls following the loss of sympathetic innervation,
organ levels of histamine apparently do not
follow this pattern. This phenomenon has not
been studied in the same detail for histamine as
it has for norepinephrine. Of the three denervated
structures studied in sheep (spleen, salivary
glands, and kidney) the histamine content of
only the spleen was found to decrease.
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The investigations of Werle and co-workers
on the histamine content of nerves have been
reviewed by Werle.U8 Werle’s results in cattle
differ from those of Euler only in a quantitative
manner; ganglia and post-ganglionic fibers of the
sympathetic system exhibited the highest titer
of histamine. Of special interest is the demon-
stration by those workers of histidine decar-
boxylase activity in autonomic fibers. This
activity, although of small magnitude, was much
greater in sympathetic trunk material than in
vagus nerve, which in turn was considerably
higher than brachial plexus and sciatic nerve.
The enzymatic conversion of histidine to his-
tamine was considerably augmented by the
addition of pyridoxal-5’-phosphate.
Euler and Astr6m38 reported release of his-
tamine from isolated splenic nerve of cattle by
electrical stimulation. The isolated nerves were
either stimulated in Ringer’s which was sub-
sequently transferred to a bath containing
a strip of guinea pig ileum, or the cut end of the
nerve was stimulated while submerged in the
gut bath. Positive responses were obtained in
both cases which were obliterated by anti-
histamine. It has not been claimed by the au-
thors that this observation bears any necessary
relationship to histamine release from nerves
under normal physiologic conditions.
The question of whether or not histamine
mediates the vasodilatation observed upon anti-
dromic stimulation of dorsal root fibers remains
a highly controversial one. Lewis and Marvin75
proposed that a histamine-like mediator was
released during antidromic stimulation of fibers
from cat paw. The hypothesis was based entirely
on indirect evidence, such as the prolongation of
reactive hyperemia by antidromic stimulation
attempted during arterial occlusion. Kibjakow69
noted that venous eiEuent collected from cat
hindlimb during faradization of dorsal roots
contained a stable material which dilated the
vessels of the rabbit ear. Kwiatkowski72 observed
that this substance apparently could be neither
acetylcholine, which is unstable in blood, nor
histamine which is devoid of dilator effect on the
rabbit ear. iVybauwi2° noted an increase in
both magnitude and duration of the antidromic
dilator response in eserinized cat limbs. Similarly,
eserinized Ringers perfusate of the limbs was
found to lower the blood pressure of another
cat. On the basis of these observations Wybauw
proposed that the response was mediated through
a cholinergic mechanism. An increase in gastric
secretion reaching a maximum 8 to 10 minutes
after stimulation of dorsal root fibers in the dog
was observed by Unbar/08 who proposed that
the gastric effect was mediated by blood-borne
histamine originating in the areas dilated by the
antidromic stimulation. In subsequent publica-
tions Ungar and Parrot&dquo;9, mo denied that this
substance was histamine, and proposed that it
resembled an adrenaline derivative in its chemical
and pharmacologic properties. The material
isolated from hindlimb venous effluent was in
most tests (blood pressure, isolated tissues, and
so on) indistinguishable from an enzymatic
product of adrenaline, adrenoxine. The chemical
nature of adrenoxine is unknown nor is it known
whether this substance may release histamine.
K wiatkowski72 in cats and Ibrahim and asso-
ciates67 in dogs have both utilized the same assay
technique for histamine (method of Barsoum
and Gaddum) and both claim to find an increase
of blood histamine in venous effluent after
antidromic stimulation. Ibrahim and co-workers
established that 5 mg per kg of antistin, pyra-
benzamine, and mepyramine were at least
partially effective in abolishing antidromic vaso-
dilatation. The ability of antihistamines to
inhibit this type of dilatation has not been
confirmed by other workers. Parrot and Lefebvre86
claimed that the degree of dilatation from
posterior root stimulation was unaffected by a
dose of antergan which abolished an equivalent
response resulting from the administration of
histamine. Holton and Perry66 were unable to
alter antidromic dilatation in the rabbit ear by
giving neoantergan. Pyribenzamine was re-
portedly ineffective against dorsal root dilatation
in the cross-perfused hindlimb of the dog, but
this same response was inhibited by a large dose
of atropine (3 to 5 mg per kg), a dose level
which, however, can produce ganglionic blockade52
(see unpublished observations by Beck, below).
Holton 65 succeeded in identifying adenosine
triphosphate (ATP) in effluent from the perfused
rabbit ear when the great auricular nerve was
stimulated antidromically. This observation helps
to substantiate the original suggestion of Holton
and Holton’4 that ATP might well be the mediator
of antidromic dilatation in the rabbit ear. It is
curious that such a conflict of opinion should
exist regarding antidromic dilatation but it
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would seem that at least some of the discrepancy
arises from a failure to carefully control the
experiments and perhaps to a lesser extent the
failure to consider species differences in the
various investigations.
Histamine levels in the blood are reportedly
increased during infusion of large quantities of
epinephrine. Eichler and Barfuss32 first reported
such an elevation in cats during infusions of
9.5 to 28.5 Ag per kg per min of epinephrine.
The findings of Eichler and Barfuss have since
been reported for man and for the dog.28,103,
104,117 All of these authors believed that the
release of histamine during the infusion of
catecholamine represented a compensatory or
&dquo;counter-regulatory&dquo; mechanism associated with
the rise in blood pressure. Mongar and Whelan85
were unable to confirm the results of Staub’03 in
man. Using the same method for the estimation
of histamine and the same quantity of epineph-
rine used by Staub, they were unable to find an
increase in histamine titer in either arterial or
venous blood. In favor of the work by Mongar
and ~Vhelan is that the average resting blood
levels of histamine reported (10 jug per liter) are
in the range that one would expect in man,
whereas the resting levels reported by Staub
went as high as 134 ~g per liter with none below
16 jug per liter. This would seem to suggest that
the substance Staub was measuring might not
have been histamine. Whelan&dquo;9 has also re-
ported that antihistamines are without effect
on the increased forearm flow witnessed in man
during intravenous epinephrine infusions.
An intriguing observation was made by Went
and Varga117 who discovered that chronic buffer
nerve denervation preparations failed to show
an elevation in blood histamine levels during
epinephrine infusions. This is highly suggestive
that the histamine release is reflex in nature,
rather than a non-specific release from peripheral
stores.
Histamine has been implicated as a mediator
of post-exercise hyperemia. Anrep and Barsoum
and associates2, 4 stimulated the sciatic nerve of
anesthetized dogs and observed an increase in
the concentration of histamine in the venous
blood emerging from the activated limb. A
similar elevation of the histamine titer was noted
upon direct stimulation of muscles whose in-
nervation had been removed by prior section of
the sciatic nerve. These results have never been
confirmed, however. It is significant to note that
Code and associates26 were unable to confirm the
results of Anrep and associates,3 although they
were able to show that cardiac muscle of the
dog (heart-lung preparation) released histamine
into the coronary sinus blood proportional to the
work performed by the heart; i.e., the stronger
the heart, the greater the quantity of histamine
released. Identical methods were used in each
investigation. Whelan&dquo;9 studied the effect of
several antihistamines on the increase in forearm
blood flow after a period of exercise. In four sub-
jects tripelennamine and antazoline did not
alter the hyperemic response to exercise.
In summary, the information in the literature
clearly shows that histamine is present in nervous
tissue and is most concentrated in sympathetic
post-ganglionic fibers. Although there appears
to be no unequivocal evidence for the existence
of a histaminergic vasodilator system in the
literature, the distribution of histamine in the
autonomic nerves is such that if a histaminergic
system exists it would most likely be mediated
over that portion of the autonomic system
classically described as the sympathetic nervous
system. This possibility is considered below.
SUMMARY OF STUDIES CARRIED OUT IN OUR
LABORATORY RELATING TO ACTIVE REFLEX
DILATATION AND ITS POSSIBLE MEDIATION
BY HISTAMINE OR A CLOSELY RELATED
SUBSTANCE ~‘
The mechanism of reflex dilatation produced
by the intravenous injection of epinephrine and
norepinephrine has been under fairly intensive
study in this laboratory for the past 5% years.
The study was stimulated by the observation
that reflex dilatation induced by intravenous
epinephrine could exceed the fall in blood pressure
produced by ganglionic blockade. It was felt
that the passive component of the reflex could
not exceed the fall in perfusion pressure produced
by chemical sympathectomy and therefore that
a portion of the reflex must have been active in
nature. Since a large portion of this work is not
yet available in the literature it will be abstracted
here to facilitate understanding of the discussion
to be given before members of the symposium.
The basic method utilized in this investigation
* The work carried out in this laboratory and
summarized in the symposium was supported by
Grant H-3946, USPHS.
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has been previously published.10 Briefly, it
consists of perfusing the innervated hindquarters
with a sigmamotor pump. A retroperitoneal
approach to the aorta is made in the flank area.
Two pairs of dorsolumbar arteries and the
inferior mesenteric artery are ligated to reduce
collateral circulation to a minimum. The aorta
is divided, a large polyethylene cannula is
placed in the proximal aorta and blood led
through a delay system to a sigmamotor pump.
The blood is then pumped to the hindquarters
through the descending aorta. The purpose of the
delay, which consists of a glass coil immersed in a
thermoregulated tank, is to retard the arrival
of intravenously administered drug so that reflex
action can become maximal in the perfused area
before the intravenously injected drug arrives
in the perfused area. With such a system,
interpretation of the reflex response is not
confounded by the local vascular actions of the
injected drug.
A variety of experiments have been carried
out utilizing this basic experimental design. It
has been shown that reflex dilatation significantly
exceeds the fall in perfusion pressure produced by
hindquarter sympathectomy..&dquo; Sympathectomy
in turn abolishes the reflex. Reflex dilatation pro-
duced by epinephrine or norepinephrine remains
after abolition of tone by optimal doses of the
norepinephrine antirelease agents demonstrating
that active reflex dilatation can occur in the
absence of sympathetic tone.92 The beta-methyl
derivative of TM 10 (SKF 6890A) is clearly
better than TM 10, bretylium or quanethidine
for the purpose of dissociating active and passive
reflex dilatation. Additional evidence for active
dilatation has been obtained by utilizing amine
oxidase inhibitors to slow the degradation rate of
norepinephrine. Under these circumstances active
reflex dilatation can occur much more rapidly
than passive dilatation. By use of the adrenergic
antirelease agents and the amine oxidase in-
hibitors, it has been possible to demonstrate
the presence of a large active component of
reflex dilatation when considerable sympathetic
tone exists, and therefore when the potential
for passive reflex dilatation is large. Chronic
pre-treatment with reserpine abolishes both
reflex constriction and reflex dilatation, but
acute treatment results in a rapid loss in reflex
dilatation at a time when reflex constriction is
actually enhanced. The mechanism whereby
reserpine blocks active reflex dilatation is un-
known. The blockade of passive reflex dilatation
upon chronic treatment can be attributed to
norepinephrine exhaustion.
Reflex dilatation is not affected by low doses
of atropine sufficient to block the sympathetic
cholinergic fibers. Larger doses of atropine are
capable of reducing reflex dilatation but such
doses also cause a parallel reduction in the
constrictor response following pre-ganglionic stim-
ulation of the sympathetic nerves indicating that
ganglionic blockade occurs at high dose levels.
Ganglion blocking agents block both reflex
dilatation and reflex constriction showing that
both the passive and active reflex systems are
ganglionated. The beta adrenergic agent, di-
chloroisoproterenol, does not block reflex dilata-
tion in doses which abolish an equivalent dilata-
tion induced by the intra-arterial injection of
isoproterenol. Dichloroisoproterenol does produce
a considerable reduction in vascular tone in
some animals which in turn reduces the absolute
magnitude of the reflex but the reduction is not
greater than that which occurs with comparable
dilating doses of glyceryl trinitrate demonstrating
that the reduction is non-specific in origin. The
results obtained with dichloroisoproterenol show
that the active reflex dilatation is not simply a
phenomenon of epinephrine reversal resulting
from a diminished neurogenic release of epineph-
rine nor can it be ascribed to the release of a
substance with purely beta adrenergic stimulating
activity.
Some of the antihistamines, particularly tri-
pelennamine and D-chlorpheniramine, produce
an essentially parallel reduction in reflex dilata-
tion and in the dilatation produced by intra-
arterial histamine.&dquo; Other antihistamines are
generally not as effective but many produce a
variable blockade. Dilatations produced by
acetylcholine, isoproterenol, glyceryl trinitrate,
bradykinin, substance P and other vascular
dilators remain essentially unchanged following
reflex and histamine blocking doses of tri-
pelennamine. The blockade of reflex dilatation
produced by the antihistamines does not appear
to be a local anesthetic action since several
local anesthetics, closely related to the anti-
histamines, but devoid of antihistaminic activity,
fail to block reflex dilatation in larger doses.
Cocaine, on the other hand, does markedly
reduce reflex dilatation but its steroisomer,
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tropacocaine, fails to block reflex dilatation in
larger local anesthetic doses. It is interesting
that cocaine has been reported to prevent the
release of histamine whereas tropacocaine may
even facilitate release.1,8 The parallel between
the two sets of observations is intriguing. A
number of histamine releasers have been tried
and many reduced reflex dilatation. Agents which
reportedly potentiate the action of histamine on
the isolated gut have been investigated for their
potentiating effect on reflex dilatation. No
regular potentiation of reflex dilatation nor of
histamine induced dilatation was observed. In
those experiments where potentiation occurred,
the reactivity to glyceryl trinitrate was also
potentiated suggesting a non-specific effect.
Several agents generally categorized under the
heading of alpha adrenergic blocking agents were
tested for their ability to block reflex dilatation.
Dibenzyline usually produced considerable re-
duction in reflex dilatation. Since histamine
induced dilatation was also markedly reduced by
dibenzyline the loss of reflex activity cannot
necessarily be ascribed to alpha adrenergic
blockade. Sometimes blockade of histamine-
induced dilatation even exceeded the degree of
reflex blockade. Several of the ergot alkaloids
blocked reflex dilatation almost completely in
large doses. Lower doses, particularly of di-
hydroergocornine, produced a dramatic reduc-
tion in reflex dilatation without (a) producing a
fall in perfusion pressure, (b) reducing the
constrictor effect of sympathetic nerve stimula-
tion, (c) decreasing the reflex constriction pro-
duced by asphyxia, afferent vagal stimulation or
lowering of the blood pressure by a hypotensive
agent, and (d) effecting a significant blockade of
intra-arterial norepinephrine. It therefore seems
unlikely that the reduction in reflex dilatation
produced by dihydroergocorine is the result of
adrenergic blockade, prevention of release of
norepinephrine from the nerve endings, ganglionic
blockade, central depression of the vasomotor
center or blockade of afferent systems. Nor
does dihydroergocornine block injected histamine.
The specific mechanism of reflex blockade remains
to be elucidated but it seems clear that the
reflex dilatation cannot be arbitrarily classified as
adenergic because these agents block the reflex
in whole or in part.
were reflex dilatation purely passive, alpha
adrenergic blockade would remove effective
sympathetic tone and consequently abolish pas-
sive reflex dilatation. If no active component were
present maximal alpha adrenergic blockade, un-
complicated by extraneous drug actions, would
therefore simulate the results obtained by
sympathectomy, or ganglion blockade. If an
active component were present, and the ad-
renergic blocker produced no effects other than
alpha adrenergic blockade, the results would
simulate those found with the norepinephrine
antirelease agents.
The antiserotonins, 2-brom-D-lysergic acid
diethylamide and 1-methyl methergine bimale-
inate, were tested for their ability to modify
reflex dilatation. Doses which were capable of
blocking the vascular constrictor action of
serotonin on the hindquarter circulation failed to
block reflex dilatation. Such doses do not block
the dilator action of serotonin. Since serotonin
has been reported to release histamine the dilator
action may well be due to release of histamine.43
This seems the more probable in that we have
been able to block the dilator response by ad-
ministration of antihistamines. Much larger doses
of the antiserotonin ergot derivatives are able to
reduce or block reflex dilatation but this may be
due to an action similar to the low dose effect
reported with dihydroergocornine. Large doses
of these antiserotonins may also block dilator
action of serotonin thought to be due to histamine
release and therefore could conceivably exert
their effect through histamine antirelease action.
A study of the afferent systems involved in
active reflex dilatation suggests that receptors
capable of evoking it are located in the carotid
sinus area and the distribution of the vagus as
well as other areas. Application of increased
pressure gradients to the sinus area by means of
a second sigmamotor pump placed in the carotid
circulation produces a reflex dilatation in the
perfused hindquarters. The evoked reflex has
both a transient and sustained component. The
larger transient component usually lasts for less
than a minute. The sustained component does
not seem to accomodate even when the increased
gradient is maintained for several minutes. The
transient component is believed to be active since
it can be obtained after the abolition of sympa-
thetic constrictor tone with the antirelease agent
SKF 6890A and can be blocked by antihistamine.
The sustained component is believed to represent
passive reflex dilatation because it is not blocked
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by antihistamine but disappears after treatment
with the antirelease agent. Stimulation of central
sinus or vagus nerves after sinusectomy and
;vagotomy results in reflex dilatation. Prolonged
stimulation of the sinus nerves results in both the
transient and sustained types of reflex dilatation
whereas stimulation of the central vagus usually
results in only the transient component.
Administration of epinephrine during inhibi-
tion of sympathetic tone by high pressure perfus-
sion of the sinuses still results in a transient
component of dilatation. After vagotomy and
effective sinusectomy (verified by the fact that
increased pressure no longer evokes a reflex)
epinephrine can evoke reflex dilatation but is
often less pronounced than the reflex dilatation
occurring before denervation of the buffer nerves.
Before sinusectomy and vagotomy norepinephrine
is a more potent reflexogenic agent than epi-
nephrine, but after these procedures epinephrine
is more potent than norepinephrine.
Veratrine and veratridine produce an active
reflex dilatation in the perfused hindquarters
along with a systemic hypotension. The reflex
dilatation and the histamine induced dilatation
are blocked essentially in parallel by anti-
histamine. Veratrine induced reflex dilatation
is abolished by combined vagotomy and si-
nusectomy but usually not by vagotomy alone.
Stimulation of the intact lumbar sympathetics
at appropriate parameters (generally low voltage,
short impulse duration) can produce rather
prominent dilatation in the perfused area which
can be blocked by antihistamine. Increasing the
voltage and impulse duration following his-
taminic blockade produces a vascular constric-
tion demonstrating an absence of local anesthesia.
After SKF 6890A stimulation of the sympathetics
results in a considerable dilatation in the perfused
area partially amenable to blockade by atropine
and partially by antihistamine.92 After chronic
pre-treatment with reserpine or SU 4029 elec-
trical stimulation produces a dilatation which
can be blocked by atropine but not by anti-
histamines. Sometimes, especially after treat-
ment with atropine, a minor dilatation, which
at present we have been unable to block, occurs
slowly and remains for sometime after the end
of the stimulus period. After chronic treatment
with reserpine and SU 4029, reflex dilatation
and reflex constriction are usually abolished,
in toto, an observation which is compatible with
the failure to block any component of the
electrically induced dilatation by antihistamines
following these agents.
Attempts to recover histamine from the venous
effluent following elicitation of the reflex have
not been successful. It appears from recovery
experiments, following intra-arterial infusion of
histamine, that the histamine which diffuses out
of the blood vessel fails to re-enter the vascular
system. These results are suggestive of a rapid
termination or binding of histamine by the
tissues. No evidence for a reduction in norepi-
nephrine content in the venous effluent was
obtained either during the reflex or following
local hindquarter sympathectomy. Intense lumbar
sympathetic stimulation, estimated to produce a
16-fold increase in norepinephrine secretion
(based on an assumed log-dose response relation-
ship which occurs with intra-arterial infusion)
increased the venous concentration of norepi-
nephrine to barely detectable levels. The results
of the assays for neurohumoral substances
therefore support neither the thesis of active
nor passive reflex dilatation.
Tracheal occlusion produces an abrupt reflex
constriction in the perfused area. When the
trachea is de-occluded a sharp dilatation occurs.
This dilatation is active in nature and reflex
in origin. It is abolished by sympathectomy and
adequate ganglionic blockade. It may remain
in large part after adequate dihydroergocornine
to abolish the active component of reflex dilata-
tion produced by intravenous epinephrine or
norepinephrine. Tracheal de-occlusion dilatation
is not blocked to any extent by antihistamines
unless tracheal occlusion produces an associated
rise in blood pressure. In this case the tracheal
occlusion reflex is evoked in conjunction with the
catecholamine-induced reflex resulting from ad-
renal release. It is this latter component which is
blocked by antihistamines when tracheal occlu-
sion produces a rise in blood pressure. The tracheal
de-occlusion reflex may at times be partially
blocked by relatively large doses of atropine.
As indicated above, Dr. Aviado82 has recently
reported active reflex dilatation following hypoxia
in animals treated with bretylium and reported
that the reflex is partially blocked by atropine.
In view of our observation that doses of atropine
from 0.5 to 3.0 mg per kg can decrease the con-
strictor response produced by lumbar sympathetic
stimulation we no longer feel secure in necessarily
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attributing the blocking effect of atropine on
this reflex to blockade of a cholinergic vaso-
dilator component. Nevertheless, it seems ap-
parent that the greater portion of this type of
active reflex dilatation is mediated by a different
substance than the reflex dilatation produced by
the intravenous injection of epinephrine and
norepinephrine.
THE NATURE OF RELEASE OF MEDIATORS FROM
NERVE ENDINGS
A curious and interesting observation arose
out of the investigation dealing with the norepi-
nephrine antirelease agents. The original aim
was simply to demonstrate that active reflex
dilatation could be preserved at a time when
norepinephrine secretion had been blocked. It
was fortunate, but purely fortuitous, that both
the first agent and the employed dose were
optimal for this demonstration, otherwise the
investigation may never have been completed. It
was soon discovered that other antirelease
agents did not always preserve reflex dilatation
at doses which were required to block norepineph-
rine release. In fact, at times reflex dilatation
was blocked out of proportion to the norepineph-
rine antirelease effect as demonstrated by various
procedures designed to evoke reflex constriction.
This observation prompted an investigation into
the higher dose effects with beta TM 10. Progres-
sive increments in dose caused, at first, a fairly
rapid loss in reflex constrictor ability with only
moderate reduction in reflex dilatation, indicating
that the lower doses had effectively removed
sympathetic tone. At these doses maximal
stimulation of the lumbar sympathetics produced
only a fall in perfusion pressure as opposed to a
large rise previous to beta TM 10. As the dose
was further increased no additional reduction
in perfusion pressure occurred, but a progressive
diminution in the remaining reflex dilatation
could be obtained.
These observations suggested that the norepi-
nephrine antirelease agents were capable of
preventing release not only of norepinephrine
but also, in appropriate doses, of the active
dilator which mediated the reflex dilatation
induced by norepinephrine inj ection. It had been
shown previously by Exley’2 that the sympathetic
nerves still conducted impulses following the
antirelease agents and we had observed that
agents like d-amphetamine could still produce a
large pressor response at a time when sympathetic
stimulation failed to produce constriction follow-
ing the antirelease agents. The fact that these
agents had some structural resemblance to other
quaternary compounds which blocked acetyl-
choline at the ganglia and neuromuscular junc-
tion, coupled with the observations above, raised
the theoretical question of whether these agents
might be blocking an acetylcholine action. The
working hypothesis was put forward that norepi-
nephrine and the active dilator mediating reflex
dilatation might be contained in independent
packets at different nerve endings or at neuroeffec-
tor sites, that a nerve impulse passing down the
sympathetics would release a quantum of acetyl-
choline which in turn would produce a tem-
porary depolarization of the packet permitting
the secretion of an aliquot of norepinephrine or
the active dilator depending on which sympa-
thetic nerves were physiologically activated.
The packet would then repolarize as the secreted
acetylcholine was hydrolyzed and secretion of
the mediator would stop. It was postulated that
the antirelease agents might prevent the de-
polarization of the packet by acetylcholine and
thus effect an antirelease action. The hypothesis
was tested by setting up a hindquarter perfusion
preparation similar to that referred to above.
Hemicholinium, an agent which prevents
synthesis of acetylcholine, was given. The animal
was placed on artificial respiration since respira-
tion will cease after this compound when the
physiologic stores of acetylcholine are depleted.
The lumbar sympathetics were repetitively
stimulated at short intervals and intravenous
norepinephrine was given intermittently.
These maneuvers were carried out with idea
of depleting existing depots of acetylcholine at
the theoretical packet. In 2 of 7 animals sympa-
thetic tone and reflex dilatation disappeared com-
pletely within 2 to 4 hours. In one of these dogs
the intravenous administration of choline (which
has been previously demonstrated to antagonize
hemicholinium) restored both sympathetic tone
and reflex dilatation. In the other animal a minor
return of sympathetic tone only was obtained.
These results were compatible with the hy-
pothesis put forth above that norepinephrine
and the active dilator are released through the
intermediate action of acetylcholine secretion by
the sympathetic nerves. The soundness of the
inference, however, was clearly based on whether
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pre-ganglionic fibers or post-ganglionic fibers
were being stimulated. If pre-ganglionic fibers
were stimulated, exhaustion of acetylcholine
could occur at the ganglion and thus lead to a
misinterpretation of our data. Before increasing
our series the counter experiment of stimulating
the lumbar sympathetics and examining the
degree of blockade with ganglion blocking agents
was therefore carried out. It was found that
large doses of hexamethonium, tetraethylam-
monium, azomethonium, pempidine and ostensin
reduced the effects of low lumbar and even upper
sacral stimulation from 60 to 100 per cent. From
the results obtained with the ganglion blocking
agents it becomes clear that the hypothesis put
forward above, that acetylcholine is involved in
the release of norepinephrine and the dilator
substance, must remain hypothetical until the
alternative possibility that the hemicholinium
blockade occurs at another site is ruled out. If
the site of stimulation in our experiments were
post-ganglionic it would require a change in
views on the mechanism of action of the ganglion
blocking agents.
It should be pointed out that Burn and Rand20
have also proposed that norepinephrine release
is brought about through the intermediary ac-
tion of acetylcholine. These authors argue that
acetylcholine is involved in the release of norepi-
nephrine for a number of reasons, the most
important of which are as follows: (1) Stimula-
tion of sympathetic nerves to various areas before
exhaustion by the releasing agent, reserpine,
produced a vasoconstriction; after exhaustion
stimulation of the same nerves produced a
dilatation, potentiated by physostigmine, and
amenable to block by atropine. (2) Acetylcholine
and nicotine can produce a constriction in the
rabbit ear before, but not after, degeneration of
nerve fibers. (3) Stimulation of the lumbar
sympathetic chain for 3 seconds produced a
decrease in arterial resistance to the hindleg of
the dog but stimulation for 30 seconds produced
a rise in resistance. (4) Stimulation of the sympa-
thetic fibers to the rabbit atria normally causes
acceleration in rate. (5) Koelle has observed
cholinesterase in sympathetic nerves which are
generally considered to be predominantly ad-
renergic (for more detailed discussion and refer-
ences see original article by Burn and Rand20).
L nquestionably the above observations are
consonant with the hypothesis put forward by
Burn and Rand, but it is worthwhile to review
these considerations from an alternative stand-
point. The autonomic nerves generally classified
as sympathetic may contain, as anatomically
distinct entities, both cholinergic and adrenergic
fibers as well as fibers mediated by other sub-
stances. Strong electrical stimulation of these
compound nerves may produce a predominant
release of norepinephrine which masks the
simultaneous release of cholinergic dilator ma-
terial (this could also apply if other dilators in
addition to acetylcholine were released). Deple-
tion of norepinephrine depots with reserpine or
prevention of norepinephrine release by anti-
release agents would now permit an unmasking
of the effect of stimulation of dilator fibers pre-
viously masked by the greater secretion of
norepinephrine from adrenergic fibers. This
&dquo;masking&dquo; concept was originally proposed by
Dale in 190629 and it would still seem a tenable
viewpoint even today. The same mixed nerve
interpretation could explain the effect of stimula-
tion of sympathetic nerves to the rabbit atria.
If a sympathetic cholinergic vasodilator system
did not exist as a distinct entity it would be
virtually impossible to explain the observations
of the Scandinavian workers (see section on
Cholinergic Mediation of Active Dilatation)
that central stimulation produced a profound
vascular dilatation in the hindlimb of the cat,
transmitted over the sympathetics, and blocked
by atropine. Clearly this secretion of acetyl-
choline cannot involve secretion of norepineph-
rine ; otherwise a constriction would occur
since this system is operative in non-drug-treated
animals. The lesser dilatation observed in other
sympathetically innervated areas upon electrical
stimulation of the sympathetics following nor-
epinephrine exhaustion by reserpine might
simply reflect a less dense distribution of dilator
fibers to those areas. Similarly, the observation
that cholinesterase is present in sympathetic
nerves may be taken to indicate that cholinergic
fibers are present in such systems or that acetyl-
choline is involved in the normal function of
many types of nerves. The observations of
Koelle and Koelle7° that only a small proportion
of the sympathetic ganglion cells stain densely
is strongly suggestive that at least two physi-
ologically discrete types of cells exist in the
sympathetic ganglia. The constriction produced
by acetylcholine and nicotine in the rabbit ear
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before, but not after degeneration, is a strong
argument for the above hypothesis; but even
in this instance the ability of an agent to promote
release of norepinephrine does not necessarily
implicate that substance as the physiologically
active agent, for many other substances can
also discharge catecholamine.
The argument regarding the immediate and
prolonged effects of lumbar sympathetic stimu-
lation is not a telling one. Similar observations
quoted by Burn have also been observed in this
laboratory. But we have also found it is possible
to obtain only dilator effects at the same elec-
trode placement, irrespective of the duration of
stimulation, if appropriate parameters of stimu-
lation are chosen. Such dilator effects soon sub-
side, usually within 30 seconds, even though no
secondary constrictor phase occurs. Discon-
tinuing the stimulation for a short period and
then repeating the stimulation permits the re-
appearance of the dilatation. By contrast, marked
constriction in the innervated area produced by
strong stimulation of the lumbar sympathetics
can be maintained for long periods. If the initial
dilatation resulted from the release of acetyl-
choline whose function was to promote the re-
lease of norepinephrine, then such release of
acetylcholine should continue as long as the
stimulation is maintained. The transient nature
of the dilatation following electrical stimulation
cannot be ascribed to a masking effect of the
dilatation by a delayed release of constrictor
substance because continuous electrical stimula-
tion, even at high voltages, following norepi-
nephrine exhaustion with reserpine or following
prevention of norepinephrine release by the
antirelease agents, produces a marked dilatation
which also soon subsides. This is similar to the
effect in the untreated animal stimulated at
appropriate parameters.
Chang and Rand24 have very recently pub-
lished a paper in support of their hypothesis
using hemicholinium. They report that treat-
ment with hemicholinium abolished the con-
traction of the vas deferens produced by hypo-
gastric stimulation, the inhibition of uterine
contraction by electrical stimulation of the hypo-
gastric nerve, inhibition of the colon by lumbar
sympathetic stimulation, and constriction of the
rabbit ear by stimulation of the superior cervical
ganglion. They reported in many instances partial
reversal of the depressed responses could be
achieved by administration of choline. These
observations are in strong support of their thesis
providing ganglionic blockade and effects on
nerve conduction can be ruled out. Although
the authors feel that they are stimulating at
post-ganglionic sites in many instances, they
apparently have not tested for the presence of
ganglia by administration of a test dose of a
large amount of ganglion blocking agent. In
view of our own findings that the ganglion block-
ing agents usually abolished most of the dilata-
tion and constriction produced by lumbar sym-
pathetic stimulation in our dog-hindquarter
preparations, it would seem wise to utilize a
test agent to confirm that the systems used by
Chang and Rand in the above investigation were
post-ganglionic. On the other hand it may be
that such large doses of ganglion blocking agent
block release from post-ganglionics. Caution
must also be excercised in interpretations of
experiments in which nerve stimulation is car-
ried on for several hours, for in some instances
the response becomes depressed or disappears
altogether without administration of drug. Un-
less the response is reversible by choline, the
result should likely be discarded. A further
thought to be borne in mind is whether trans-
mission fails in the nerve rather than at its end-
ing. The observation that, after hemicholinium,
phrenic nerve activity still occurs at a time when
neuromuscular transmission is lost, does not
necessarily permit the inference that the nerve
is the least susceptible link in the chain of other
systems.83
The concept expressed by Burn and Rand20
that acetylcholine serves as an intermediate in
the neurogenic release of norepinephrine is most
certainly intriguing for it would give a unifying
concept of neurohumoral release and it would
also represent yet another demonstration of the
already magnificent receptor specificity to phar-
macologic agents capable of blocking processes
excited by acetylcholine. At the moment, how-
ever, it would seem that the results should be
accepted with some measure of reserve until
all possible objections have been removed.
Although our own hypothesis is generally in
accord with the view of Burn and Rand it ap-
pears to differ fundamentally in that we believe
the sympathetics contain some discrete choliner-
gic fibers which release acetylcholine at their
post-ganglionic endings as the neuro-effector
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substance, per se, and that this acetylcholine is
capable of producing marked dilatation without
norepinephrine secretion. Anatomically different
fibers secrete norepinephrine through the de-
polarizing action of acetylcholine on packets
either within the nerve or in exquisite proximity
to this &dquo;adrenergic&dquo; ending. Local destruction
of this latter acetylcholine would normally occur
rapidly enough to prevent its exerting a vascular
action. We also envisage other dilator fibers
which liberate histamine or a substance with
similar pharmacologic properties. This dilator
substance is released through a mechanism simi-
lar to the release of norepinephrine and is re-
sponsible for the active component of reflex
dilatation brought about by injection of epi-
nephrine, norepinephrine and the stimulation of
various afferent systems. There is also the prob-
lem of explaining the active reflex dilatation
produced by asphyxia since it is also transmitted
over the sympathetics and appears to be differ-
ent at least in part from the system of Folkow
and Uvnas, and that mediating active dilatation
induced by intravenous norepinephrine and
epinephrine.
Thus there is at least some evidence for the
existence of at least four functionally independent
systems. It is difficult to envisage how these
systems can act more or less independently unless
they are mediated over separate pathways.
The release of different mediators from different
&dquo;nerve endings&dquo; by the same agent would not
seem incompatible with the hypothesis that each
mediator is released from anatomically different
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